News

LICR stated has partnered with Cancer Research Institute to establish the Cancer Vaccine Collaborative, a coordinated global network of laboratory and clinical sites with expertise in immunology, to

The randomised, double-blind, placebo-controlled, parallel-group, Phase II study was conducted in 25 centers across US, Canada, Europe and Israel and included 559 patients with ALS. In the trial,

i3’s customers are expected to benefit from ChinaGate’s expertise in overseeing clinical trials, submitting filings, obtaining licenses and navigating the regulatory process. ChinaGate’s customers will gain access to

Metronidazole injection, USP is an intravenous antimicrobial product used to treat infections and is supplied in a single dose plastic container. The lot numbers being recalled are: A090742,

As per the terms of the renewed license and supply agreement, Merck Serono will have marketing rights worldwide, except the US. Columbia Laboratories retains US marketing rights to

Biotage said that it is acquiring the RapidTrace and TurboVap product lines and all associated assets. Approximately eight employees of Caliper are expected to be offered employment in

Reportedly, the licensing is part of the Advaxis’ 20-year exclusive worldwide license agreement with UPenn. It covers patents that expire as late as 2023. As per the terms

According to the Miraculins, the test has been optimized for serum and urine in the ELISA format. As a further benefit, Miraculins’ sEng test requires less sample volume

BaroFeron is a proprietary recombinant human interferon beta being developed for the treatment of multiple sclerosis. Matthew Brewer, president and CEO of BaroFold, said: “BaroFeron is an optimised,